Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
401-04-003 / 271-01-059 ISMRM Abstract

Direct dynamic 2H MRSI and metabolic modelling for 3D characterization of glucose oxidative metabolism in rats brain

Primary: Contrast Mechanisms - Deuterium
Secondary: Contrast Mechanisms - Spectroscopy
401-04-003 · Metabolism · Tuesday, 12 May, 4:00 PM–5:50 PM · Hall 1A
271-01-059 · ISMRM AMPC Selected Posters · Sunday, 10 May, 7:00 AM–2:00 PM · Traditional Posters
Keywords: Modelling Metabolic pathways Deuterium MRSI Deuterium-labeled glucose 1H-MRSI
Accepted
Alessio Siviglia 1,2, Brayan Alves1,2, Thanh Phong Lê1,2, Cristina Cudalbu1,2, Bernard Lanz1,2
1CIBM Center for Biomedical Imaging, Lausanne, Switzerland
2CIBM Pre-Clinical Imaging EPFL Metabolic Imaging Section, École Polytechnique Fédérale de Lausanne - EPFL, Lausanne, Switzerland
Presenting Author: Alessio Siviglia

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. H. M. De Feyter et al., ‘Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo’, Sci. Adv., vol. 4, no. 8, p. eaat7314, Aug. 2018, doi: 10.1126/sciadv.aat7314. [doi]
2. H. M. De Feyter and R. A. de Graaf, ‘Deuterium metabolic imaging – Back to the future’, J. Magn. Reson., vol. 326, p. 106932, May 2021, doi: 10.1016/j.jmr.2021.106932. [doi]
3. E. S. Roig et al., ‘Deuterium Metabolic Imaging (DMI) of the Human Brain in vivo at 7T’, Magn. Reson. Med., vol. 89, no. 1, pp. 29–39, Jan. 2023, doi: 10.1002/mrm.29439. [doi]
4. B. Lanz, R. Gruetter, and J. M. N. Duarte, ‘Metabolic Flux and Compartmentation Analysis in the Brain In vivo’, Front. Endocrinol., vol. 4, p. 156, Oct. 2013, doi: 10.3389/fendo.2013.00156. [doi]
5. P. G. Henry et al., ‘In vivo 13C NMR spectroscopy and metabolic modeling in the brain: a practical perspective’, Magn Reson Imag, vol. 24, no. 4, Art. no. 4, 2006, doi: 10.1016/j.mri.2006.01.003. [doi]
6. D. Simicic et al., ‘Fast high-resolution metabolite mapping in the rat brain using 1H-FID-MRSI at 14.1T’, Jul. 06, 2023, arXiv: arXiv:2307.03261. doi: 10.48550/arXiv.2307.03261. [doi]
7. B. Alves et al., ‘Noise-reduction techniques for 1H-FID-MRSI at 14.1T: Monte-Carlo validation & in vivo application’, Sep. 20, 2023, arXiv: arXiv:2309.11204. doi: 10.48550/arXiv.2309.11204. [doi]
8. Z. Starčuk and J. Starčuková, ‘Quantum-mechanical simulations for in vivo MR spectroscopy: Principles and possibilities demonstrated with the program NMRScopeB’, Anal. Biochem., vol. 529, pp. 79–97, 2017, doi: 10.1016/j.ab.2016.10.007. [doi]
9. L. Vanhamme and S. V. Huffel, ‘AMARES: Advanced Method for Accurate, Robust and Efficient Spectral fitting of MRS data with use of prior knowledge’, vol. 43, no. 129, Art. no. 129, 1997.
10. S. W. Provencher, ‘Estimation of metabolite concentrations from localized in vivo proton NMR spectra’, Magn. Reson. Med., vol. 30, no. 6, pp. 672–679, 1993, doi: 10.1002/mrm.1910300604. [doi]
11. AlvBrayan, AlvBrayan/MRS4Brain-toolbox. (May 14, 2025). MATLAB. Accessed: Jun. 12, 2025. [Online]. Available: https://github.com/AlvBrayan/MRS4Brain-toolbox
12. J. M. N. Duarte, B. Lanz, and R. Gruetter, ‘Compartmentalized cerebral metabolism of [1,6- 13C]glucose determined by in vivo 13C NMR spectroscopy at 14.1 T’, Front. Neuroenergetics, no. JUN, Art. no. JUN, 2011, doi: 10.3389/fnene.2011.00003. [doi]
13. P.-G. Henry, V. Lebon, F. Vaufrey, E. Brouillet, P. Hantraye, and G. Bloch, ‘Decreased TCA cycle rate in the rat brain after acute 3-NP treatment measured by in vivo1H-13C NMR spectroscopy’, J. Neurochem., vol. 82, no. 4, pp. 857–866, 2002, doi: 10.1046/j.1471-4159.2002.01006.x. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/401-04-003